https://www.selleckchem.com/pr....oducts/pf-04418948.h
There are no valid data indicating evidence for differing algorithms for chemoprophylaxis or antimalarial treatment in semi-immune versus nonimmune malaria patients. So far, no robust biomarkers exist that properly reflect anti-parasite or clinical immunity. Until they are found, researchers should rigorously stratify their study results using surrogate markers, such as duration of time spent outside a malaria-endemic country. Copyright © 2020 American Society for Microbiology.SUMMARYThe causative agent of melioidosis, Burkholderia
Like
Comment
Share
